Fidelity Investments’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.8K | Sell |
19,945
-1,158,707
| -98% | -$4.63M | ﹤0.01% | 3701 |
|
|
2025
Q1 | $1.07M | Sell |
1,178,652
-645,806
| -35% | -$588K | ﹤0.01% | 2655 |
|
|
2024
Q4 | $5.05M | Sell |
1,824,458
-654,231
| -26% | -$1.81M | ﹤0.01% | 2149 |
|
|
2024
Q3 | $13M | Buy |
2,478,689
+1,262
| +0.1% | +$6.6K | ﹤0.01% | 1844 |
|
|
2024
Q2 | $11M | Buy |
2,477,427
+509,995
| +26% | +$2.27M | ﹤0.01% | 1841 |
|
|
2024
Q1 | $15.1M | Sell |
1,967,432
-304,874
| -13% | -$2.34M | ﹤0.01% | 1751 |
|
|
2023
Q4 | $9.68M | Sell |
2,272,306
-192,926
| -8% | -$822K | ﹤0.01% | 1856 |
|
|
2023
Q3 | $10.4M | Buy |
2,465,232
+1,716,398
| +229% | +$7.21M | ﹤0.01% | 1819 |
|
|
2023
Q2 | $4.17M | Buy |
748,834
+45,838
| +7% | +$255K | ﹤0.01% | 2116 |
|
|
2023
Q1 | $4.03M | Buy |
+702,996
| New | +$4.03M | ﹤0.01% | 2156 |
|
|
2022
Q4 | – | Sell |
-609,380
| Closed | -$1.63M | – | 5477 |
|
|
2022
Q3 | $1.63M | Sell |
609,380
-439
| -0.1% | -$1.18K | ﹤0.01% | 2479 |
|
|
2022
Q2 | $2.91M | Buy |
609,819
+225
| +0% | +$1.07K | ﹤0.01% | 2385 |
|
|
2022
Q1 | $2.49M | Buy |
609,594
+214
| +0% | +$875 | ﹤0.01% | 2548 |
|
|
2021
Q4 | $4.16M | Hold |
609,380
| – | – | ﹤0.01% | 2407 |
|
|
2021
Q3 | $7.06M | Hold |
609,380
| – | – | ﹤0.01% | 2256 |
|
|
2021
Q2 | $10.4M | Hold |
609,380
| – | – | ﹤0.01% | 2094 |
|
|
2021
Q1 | $12.1M | Hold |
609,380
| – | – | ﹤0.01% | 1969 |
|
|
2020
Q4 | $12.6M | Hold |
609,380
| – | – | ﹤0.01% | 1891 |
|
|
2020
Q3 | $16M | Buy |
+609,380
| New | +$16M | ﹤0.01% | 1660 |
|